Pneumagen Ltd
Pneumagen is a Phase 2 clinical stage company focusing on the development of Neumifil a broad-spectrum, intra-nasal, anti-viral, for the prevention of infection and viral exacerbation of disease such as COPD & Asthma.
Pneumagen is a Phase 2 clinical stage company focusing on the development of Neumifil a broad-spectrum, intra-nasal, anti-viral, for the prevention of infection and viral exacerbation of disease such as COPD & Asthma.